{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:52:15Z","timestamp":1782222735607,"version":"3.54.5"},"reference-count":17,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"ICU Medical","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2025,9,22]]},"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1136\/ejhpharm-2025-004572","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T08:00:22Z","timestamp":1762848022000},"page":"367-374","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["NHS Yellow Cover Document integrity performance assessment of two needle-free closed system transfer devices as terminal closure\/access for Luer-Lock syringes and IV bags"],"prefix":"10.1136","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6994-1966","authenticated-orcid":false,"given":"Alan Shaun","family":"Wilkinson","sequence":"first","affiliation":[{"name":"Biopharma Stability Testing Laboratory Limited, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laima","family":"Ozolina","sequence":"additional","affiliation":[{"name":"Biopharma Stability Testing Laboratory Limited, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2840-1979","authenticated-orcid":false,"given":"Romana","family":"Bon","sequence":"additional","affiliation":[{"name":"Biopharma Stability Testing Laboratory Limited, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate E","family":"Walker","sequence":"additional","affiliation":[{"name":"Biopharma Stability Testing Laboratory Limited, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wallace","sequence":"additional","affiliation":[{"name":"Biopharma Stability Testing Laboratory Limited, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"2026062306251104000_33.4.367.1","unstructured":"Wild CP , Weiderpass E , Stewart BW , eds. International Agency for Research on Cancer . Lyon, France: International Agency for Research on Cancer, 2020."},{"key":"2026062306251104000_33.4.367.2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31937"},{"key":"2026062306251104000_33.4.367.3","unstructured":"National Institute for Occupational Safety and Health . Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. 2004. Available: http:\/\/www.cdc.gov\/niosh\/"},{"key":"2026062306251104000_33.4.367.4","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0b013e3181f72b63"},{"key":"2026062306251104000_33.4.367.5","doi-asserted-by":"publisher","DOI":"10.1177\/1078155213498630"},{"key":"2026062306251104000_33.4.367.6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/1078155217726160","article-title":"Survey of guidelines and current practices for safe handling of antineoplastic and other hazardous drugs used in 24 countries","volume":"25","author":"Mathias","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"2026062306251104000_33.4.367.7","first-page":"S1","article-title":"ISOPP standards for the safe handling of cytotoxics","volume":"28","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"2026062306251104000_33.4.367.8","doi-asserted-by":"publisher","DOI":"10.1177\/1078155214544993"},{"key":"2026062306251104000_33.4.367.9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/annweh\/wxz010","article-title":"Reduction of Contamination with Antibiotics on Surfaces and in Environmental Air in Three European Hospitals Following Implementation of a Closed-System Drug Transfer Device","volume":"63","author":"Sessink","year":"2019","journal-title":"Ann Work Expo Health"},{"key":"2026062306251104000_33.4.367.10","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.12968\/bjon.2020.29.10.S15","article-title":"Use of a closed-system drug transfer device reduces contamination with doxorubicin during bolus injection","volume":"29","author":"Marler-Hausen","year":"2020","journal-title":"Br J Nurs"},{"key":"2026062306251104000_33.4.367.11","unstructured":"Santillo M , Field A , Henderson J , et al . Guidance on handling of injectable cytotoxic drugs in clinical areas in NHS hospitals in the UK. 2018. Available: https:\/\/www.sps.nhs.uk\/wp-content\/uploads\/2018\/07\/Guidance-on-Handling-Cytotoxics-Ed-1-July-2018.pdf"},{"key":"2026062306251104000_33.4.367.12","doi-asserted-by":"crossref","unstructured":"Sessink PJ , Barry B , Dunbar L , et al . Workflow evaluation of environmental contamination with hazardous drugs during compounding and administration in an UK hospital. J Oncol Pharm Pract 2024;10781552241285138. doi:10.1177\/10781552241285138","DOI":"10.1177\/10781552241285138"},{"key":"2026062306251104000_33.4.367.13","unstructured":"NHS Pharmaceutical Quality Assurance Committee . Protocols for the integrity testing of syringes. n.d. Available: https:\/\/pasg.nhs.uk\/downloads.php?did=266"},{"key":"2026062306251104000_33.4.367.14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/ejhpharm-2021-003148","article-title":"Integrity performance assessment of a closed system transfer device syringe adaptor lock as a terminal closure for Luer-Lock syringes","volume":"31","author":"Wilkinson","year":"2023","journal-title":"Eur J Hosp Pharm"},{"key":"2026062306251104000_33.4.367.15","first-page":"31","article-title":"Dose-banding of cancer chemotherapy","volume":"51","author":"Sewell","year":"2010","journal-title":"Hospital Pharmacy Europe"},{"key":"2026062306251104000_33.4.367.16","unstructured":"European Pharmacopoeia . 3.2.9 Rubber closures for containers for aqueous parenteral preparations, for powders and for freeze-dried powders. Available: https:\/\/www.biomed.co.th\/downloads\/EP7-3.2.9-Rubber-closures.pdf"},{"key":"2026062306251104000_33.4.367.17","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2022-003604"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2025-004572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:25:35Z","timestamp":1782221135000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2025-004572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,6,23]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/ejhpharm-2025-004572"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2025-004572","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]}}}